Effect of the combination of Leptadenia hastata (pers) decne and Momordica balsamina linn leaf extracts on lipid profile of streptozotocin-induced diabetic rats

• Published in: Future journal of pharmaceutical sciences 2021-05, Vol.7 (1), p.110-7, Article 110
• Main Authors: Kabir, Nafisatu, Alhaji, Umar Ismail, James, Dorcas Bolanle, Inuwa, Hajia Mairo, Atiku, Muhammad Kano
• Format: Article
• Language: English
• Subjects: aqueous extract; Blood glucose; Diabetes; Drug dosages; Glucose; Herbal medicine; Hyperglycemia; Hyperlipidemia; Hypertension; Insulin resistance; Laboratory animals; Leptadenia hastata; Lipid profile; Lipids; Lipoproteins; Medicine; Medicine & Public Health; Metabolic disorders; Momordica balsamina; Pharmaceutical sciences; Proteins; Rodents; Streptozotocin
• ISSN: 2314-7253; 2314-7245; 2314-7253
• DOI: 10.1186/s43094-021-00263-x

Background Changes in blood lipid level (dyslipidemia) play a central role in the onset and pathogenesis of macrovascular complications of diabetes mellitus. Traditional herbal healers commonly use anti-diabetic polyherbal formulations to provide a multi-therapeutic approach for the treatment of diabetes mellitus and its associated complications. The effect of the aqueous leaf extracts of Leptadenia hastata (pers) Decne, Momordica balsamina Linn and their combination on lipid profile of streptozotocin (STZ)-induced diabetic rats was therefore evaluated in the present study. Results We evaluated the serum lipid profile and blood glucose level of STZ-induced diabetic rats (60 mg/kg body weight) treated with the aqueous leaf extracts of L. hastata (400 mg/kg) and M. balsamina (200 mg/kg) alone and in combination (400 + 200 mg/kg) after a period of 4 weeks. A significantly decreased (p < 0.05) level of total cholesterol (TC), triglyceride (TG), very low-density lipoprotein (VLDL) and low-density lipoprotein (LDL) cholesterol levels and increased (p < 0.05) level of high-density lipoprotein (HDL) cholesterol was observed in all the treated groups when compared to the untreated diabetic rats. Furthermore, the combination treatment was potentially a more effective blood lipid-lowering (p < 0.05) agent when compared to the single treatments. Conclusion Results from this study demonstrated the blood lipid-lowering potential of the aqueous leaf extracts of L. hastata , M. balsamina , and their combination. However, the polyherbal combination could be more potent in controlling diabetes mellitus, associated dyslipidemia, and its complications.